According to Vertex Pharmaceuticals's latest financial reports and stock price the company's current number of shares outstanding is 258,000,000. At the end of 2023 the company had 258,000,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 0.25 B | 0.43% |
2022 | 0.25 B | 0.9% |
2021 | 0.25 B | -2.09% |
2020 | 0.26 B | 0.79% |
2019 | 0.25 B | 1.23% |
2018 | 0.25 B | 1.32% |
2017 | 0.25 B | 2.49% |
2016 | 0.24 B | 1.02% |
2015 | 0.24 B | 1.98% |
2014 | 0.23 B | 3.03% |
2013 | 0.23 B | 7.76% |
2012 | 0.21 B | 4.18% |
2011 | 0.20 B | 2.55% |
2010 | 0.20 B | 12.39% |
2009 | 0.17 B | 27.57% |
2008 | 0.14 B | 7.77% |
2007 | 0.13 B | 15.25% |
2006 | 0.11 B | 19.25% |
2005 | 94.59 M | 20.13% |
2004 | 78.74 M | 2.17% |
2003 | 77.06 M | 1.43% |
2002 | 75.97 M | 1.74% |
2001 | 74.68 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | 2,407,200,000 | 833.02% | ๐บ๐ธ USA |
AbbVie ABBV | 1,765,940,733 | 584.47% | ๐บ๐ธ USA |
Gilead Sciences GILD | 1,248,000,000 | 383.72% | ๐บ๐ธ USA |
Merck MRK | 2,554,166,667 | 889.99% | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | 2,057,000,000 | 697.29% | ๐บ๐ธ USA |
Enanta Pharmaceuticals
ENTA | 21,088,000 | -91.83% | ๐บ๐ธ USA |